from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1989c/-

LFCtreatmentdescriptionclass of inhibitor

1.820

Amikacinug/mL Amikacintranslation

1.129

Cap5-10ug/mL Capreomycintranslation

2.942

Rox10-50 ug/mL Roxithromycintranslation

0.464

SM2-5 ug/mL Streptomycintranslation

3.231

Tet5-10 ug/mL Tetracyclinetranslation

0.380

Rif0.2-5ug/mL Rifampicintranscription

-0.176

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.225

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.423

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.375

CPZ10-50 ug/mL Chlorpromazinerespiration

0.052

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.693

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.840

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.765

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.634

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.525

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.382

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.397

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.296

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.121

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.151

KCN5-20 ug/mL Potassium cyaniderespiration

-0.864

NaN30.2-2 mM Sodium aziderespiration

-0.172

Nigericin50 uM Nigericinrespiration

0.357

TRC10-150 ug/mL Triclosanrespiration

0.453

TRZ10-25 ug/mL Thioridazinerespiration

2.797

Valinomycin0.5-10 uM Valinomycinrespiration

-0.323

ZnSO42 mM ZnSO4respiration

-0.184

menadione6-10 ug/mL Menadionerespiration

-0.196

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.707

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.404

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.833

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.259

NRP_1Non-replicating persistence stage 1dosRassociated

-0.509

Amp0.2mg/mL AmpicillincellWall

-0.592

Cephalexin20-100 ug/mL CephalexincellWall

-0.473

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.053

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.431

EMB10-20 ug/mL EthambutolcellWall

-0.208

Eta12-40 ug/mL EthionamidecellWall

-0.536

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.137

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.559

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.883

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

BZA0.12 mg/mL BenzamidearomaticAmides

0.000

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.000

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.000

H2O24 mM hydrogen peroxideDNAdamaging

-0.627

Levo10 ug/mL LevofloxacinDNAdamaging

0.000

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.286

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.535

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.000

UVUV-irradiationDNAdamaging

0.096

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.634

Antimycin12.5-50 ug/mL Antimycin A?

-0.586

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.655

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.677

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.595

PA8240.2-2 ug/mL PA-824?

0.080

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.572

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.165

Verapamil50 uM Verapamil?

-0.061

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.646

methoxatin10-20 ug/mL Methoxatin?